Hypertension in Breast Cancer Patients Receiving Bevacizumab
Clinical trial NCT00674011 · TERMINATED
Trial details
- NCT number
- NCT00674011
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.